全文获取类型
收费全文 | 1486423篇 |
免费 | 102038篇 |
国内免费 | 3242篇 |
专业分类
耳鼻咽喉 | 21808篇 |
儿科学 | 44735篇 |
妇产科学 | 42134篇 |
基础医学 | 208797篇 |
口腔科学 | 44930篇 |
临床医学 | 121301篇 |
内科学 | 295791篇 |
皮肤病学 | 34432篇 |
神经病学 | 118573篇 |
特种医学 | 57336篇 |
外国民族医学 | 436篇 |
外科学 | 225986篇 |
综合类 | 31751篇 |
现状与发展 | 6篇 |
一般理论 | 459篇 |
预防医学 | 110718篇 |
眼科学 | 35392篇 |
药学 | 111885篇 |
4篇 | |
中国医学 | 3592篇 |
肿瘤学 | 81637篇 |
出版年
2018年 | 16427篇 |
2017年 | 12464篇 |
2016年 | 13444篇 |
2015年 | 15050篇 |
2014年 | 20191篇 |
2013年 | 30655篇 |
2012年 | 42431篇 |
2011年 | 44861篇 |
2010年 | 25653篇 |
2009年 | 23788篇 |
2008年 | 41737篇 |
2007年 | 45438篇 |
2006年 | 45641篇 |
2005年 | 44073篇 |
2004年 | 42556篇 |
2003年 | 41085篇 |
2002年 | 40227篇 |
2001年 | 67980篇 |
2000年 | 70239篇 |
1999年 | 59158篇 |
1998年 | 15297篇 |
1997年 | 13874篇 |
1996年 | 13340篇 |
1995年 | 12583篇 |
1992年 | 44792篇 |
1991年 | 43062篇 |
1990年 | 42352篇 |
1989年 | 41079篇 |
1988年 | 38424篇 |
1987年 | 37781篇 |
1986年 | 36312篇 |
1985年 | 34430篇 |
1984年 | 25770篇 |
1983年 | 21864篇 |
1982年 | 13085篇 |
1981年 | 11940篇 |
1979年 | 25048篇 |
1978年 | 17806篇 |
1977年 | 15538篇 |
1976年 | 14039篇 |
1975年 | 16065篇 |
1974年 | 19106篇 |
1973年 | 18631篇 |
1972年 | 17846篇 |
1971年 | 16703篇 |
1970年 | 15837篇 |
1969年 | 15335篇 |
1968年 | 14468篇 |
1967年 | 12922篇 |
1966年 | 12063篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
51.
52.
53.
54.
E. Niclas Jonsson Rujia Xie Scott F. Marshall Rosalin H. Arends 《British journal of clinical pharmacology》2016,81(4):688-699
AimsThe aims were to 1) develop the pharmacokinetics model to describe and predict observed tanezumab concentrations over time, 2) test possible covariate parameter relationships that could influence clearance and distribution and 3) assess the impact of fixed dosing vs. a dosing regimen adjusted by body weight.MethodsIndividual concentration–time data were determined from 1608 patients in four phase 3 studies conducted to assess efficacy and safety of intravenous tanezumab. Patients received two or three intravenous doses (2.5, 5 or 10 mg) every 8 weeks. Blood samples for assessment of tanezumab PK were collected at baseline, 1 h post‐dose and at weeks 4, 8, 16 and 24 (or early termination) in all studies. Blood samples were collected at week 32 in two studies. Plasma samples were analyzed using a sensitive, specific, validated enzyme‐linked immunosorbent assay.ResultsA two compartment model with parallel linear and non‐linear elimination processes adequately described the data. Population estimates for clearance (CL), central volume (V
1), peripheral volume (V
2), inter‐compartmental clearance, maximum elimination capacity (VM) and concentration at half‐maximum elimination capacity were 0.135 l day–1, 2.71 l, 1.98 l, 0.371 l day–1, 8.03 μg day–1 and 27.7 ng ml–1, respectively. Inter‐individual variability (IIV) was included on CL, V
1, V
2 and VM. A mixture model accounted for the distribution of residual error. While gender, dose and creatinine clearance were significant covariates, only body weight as a covariate of CL, V
1 and V
2 significantly reduced IIV.ConclusionsThe small increase in variability associated with fixed dosing is consistent with other monoclonal antibodies and does not change risk : benefit. 相似文献
55.
56.
Wai Man Mandy Chan Yik Weng Yew Thiam Seng Colin Theng Choon Fong Liew Hazel H Oon 《Singapore medical journal》2020,61(4):194
INTRODUCTIONPsoriasis is a chronic inflammatory condition that affects the skin and joints, and is associated with cardiovascular risk factors, including metabolic syndrome (MetS). We aimed to assess the prevalence of MetS in patients with psoriasis and determine whether there was a correlation between psoriasis severity and MetS in a Singapore population.METHODSThis was a cross-sectional study of patients with psoriasis, aged 18–69 years, who attended a tertiary dermatology referral centre in Singapore from October 2007 to February 2009. Fasting glucose, lipids, blood pressure, Psoriasis Area and Severity Index, and body mass index were measured. MetS was diagnosed in the presence of three or more criteria of the modified National Cholesterol Education Program Adult Treatment Panel III.RESULTSAmong 338 patients with psoriasis, there were 238 (70.4%) men and 100 (29.6%) women, who were Chinese (n = 228; 67.5%), Malay (n = 52; 15.4%) and Indian (n = 58; 17.2%). The prevalence of MetS was 45.1%. MetS was 44% more prevalent in patients older than 50 years (p = 0.02). Malay patients with psoriasis were significantly more likely to have hypertriglyceridaemia, elevated fasting plasma glucose and abdominal obesity. There was no significant correlation between psoriasis severity and risk of MetS.CONCLUSIONThe prevalence of MetS in patients with psoriasis in Singapore was 45.1%, or nearly threefold higher than the Singapore general population. Patients with psoriasis should be screened yearly for MetS and any modifiable cardiovascular risk factors should be actively controlled. 相似文献
57.
58.
59.
Andres Eduardo Campuzano-García Bertha Torres-Alvarez Diana Hernández-Blanco 《Journal of cosmetic and laser therapy》2015,17(4):213-215
Hailey–Hailey disease (HHD), also known as benign familial pemphigus, is an autosomal dominant skin condition that affects the adhesion of epidermal keratinocytes. Although the initial manifestation of flaccid vesicles on erythematous or normal skin in flexure sites frequently goes unnoticed, large, macerated, exudative plaques of superficial erosions with crusting are observed at the time of diagnosis. There is no specific treatment for HHD, and most cases are symptomatically supported. However, infrared laser ablation has been somewhat helpful. We present a case successfully treated with fractional CO2 laser showing a long-term favourable outcome and no adverse effects. Thus, this modality could be an alternative to full ablation for this condition. 相似文献
60.
Alejandra Gordillo Hernández Eduardo Dominguez-Adame Lanuza Auxiliadora Cano Matias Rosario Perez Huertas Katherine Maria Gallardo Rodriguez Purificacion Gallinato Perez Fernando Oliva Mompean 《World journal of gastrointestinal surgery》2015,7(8):170-173
Gangliocytic paragangliomas are rare tumors that almost exclusively occur within the second portion of the duodenum. Although these tumors generally have a benign clinical course, they have the potential to recur or metastasize to regional lymph nodes. The case report presented here describes a 57-year-old female patient with melena, progressive asthenia, anemia, and a mass in the second-third portion of the duodenum that was treated by local excision. The patient was diagnosed with a friable bleeding tumor. The histologic analysis showed that the tumor was a 4 cm gangliocytic paraganglioma without a malignant cell pattern. In the absence of local invasion or distant metastasis, endoscopic resection represents a feasible, curative therapy. Although endoscopic polypectomy is currently considered the treatment of choice, it is not recommended if the size of the tumor is > 3 cm and/or there is active or recent bleeding. Patients diagnosed with a gangliocytic paraganglioma should be closely followed-up for possible local recurrence. 相似文献